News

Blocking CD200R1 protein offers new strategy for treatment-resistant blood cancers
Immunotherapy has revolutionized cancer treatment by mobilizing the immune system to attack tumor cells. Major advances, such as immune checkpoint inhibitors (notably against the PD-1 protein), have ...
Business Wire4d
U.S. Food and Drug Administration Approves Nuvation Bio’s IBTROZI™ (taletrectinib), a Next-Generation Oral Treatment for Advanced ROS1-Positive Non-Small Cell Lun…
Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer ...
Renal & Urology News4d
Phase 3 Trial Results Show Sibeprenlimab Reduces Proteinuria in IgA Nephropathy
Sibeprenlimab clinically reduces proteinuria in adults with immunoglobulin A nephropathy (IgAN), according to data from a prespecified analysis of the phase 3 VISIONARY trial. The findings were ...
C&EN2d
Versatile Electron-Collecting Interfacial Layer by in Situ Growth of Silver Nanoparticles in Nonconjugated Polyelectrolyte Aqueous Solution for Polymer Solar Cells
† Institute of Polymers/College of Chemistry, and ‡ Jiangxi Provincial Key Laboratory of New Energy Chemistry, Nanchang University, 999 Xuefu Avenue, Nanchang 330031, China Article Views are the ...
C&EN6d
Investigations into Inhibitor Type and Mode, Simulated Gastrointestinal Digestion, and Cell Transport of the Angiotensin I-Converting Enzyme–Inhibitory Peptides in Pacific ...
Food, Nutrition, and Health Program, Faculty of Land and Food Systems, 2205 East Mall, The University of British Columbia, Vancouver, British Columbia, Canada, V6T 1Z4 * Corresponding author.